Loading provider…
Loading provider…
Surgery Physician in New York, NY
NPI: 1316114390Primary Employer
Mskcc Surgery Group
mskcc.org
HQ Phone
Get MD, PHD Charlotte's Phone Numberphone_androidMobile
Get MD, PHD Charlotte's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
NY State Medical License
2006 - 2027
CT State Medical License
1999 - 2015

American Board of Surgery
Surgery
Memorial Sloan Kettering Cancer Center
Fellowship • Complex General Surgical Oncology
2006 - 2008
Yale-New Haven Medical Center
Residency • Surgery
1997 - 2006
The Robert Larner, M.D. College of Medicine
uvm.edu
Medical School
Until 1997
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99212Established patient outpatient visit, total time 10-19 minutes | 179 | 283 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 83 | 83 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 31 | 37 |
| 4 | 12034Repair of wound (7.6 to 12.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | 25 | 25 |
| 5 | 99213Established patient office or other outpatient visit, typically 15 minutes | 22 | 23 |
Locoregional Lymphadenectomy in the Surgical Management of Anorectal Melanoma
Authors: Philip Paty, Jinru Shia, Julio Garcia-Aguilar, Danielle Bello, Martin Weiser, Garrett Nash
Journal: Ann Surg Oncol
Publication Date: 2013-01-18
Prognosis of acral melanoma: a series of 281 patients.
Authors: Richard Carvajal, Danielle Bello, Daniel Coit
Publication Date: 2013-02-24
Authors: Heather Neuman, Travis Grotz, Nabil Wasif, Mark Faries, Jeffrey Wayne, Sabino Zani, Jeffrey Farma, Bruce Averbook, Douglas Tyler, Alicia Terando, James Jakub, Amod Sarnaik, Jeffrey Wayne, Karl Bilimoria
Publication Date: 2015-11-25
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Intervention / Treatment: DRUG: Pembrolizumab, PROCEDURE: Isolated Limb Infusion, DRUG: infusion of melphalan and dactinomycin
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: Pembrolizumab, BIOLOGICAL: Talimogene Laherparepvec
Lead Sponsor: Mayo Clinic
Intervention / Treatment: PROCEDURE: Minimally invasive inguinal lymph node dissection